MRVI
Maravai LifeSciences Holdings Inc
Price:  
1.77 
USD
Volume:  
2,242,188.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRVI EV/EBITDA

-87.4%
Upside

As of 2025-04-22, the EV/EBITDA ratio of Maravai LifeSciences Holdings Inc (MRVI) is 159.70. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRVI's latest enterprise value is 455.61 mil USD. MRVI's TTM EBITDA according to its financial statements is 2.85 mil USD. Dividing these 2 quantities gives us the above MRVI EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 14.4x - 20.8x 17.6x
Forward P/E multiples 23.7x - 27.2x 26.1x
Fair Price 0.14 - 0.28 0.22
Upside -92.1% - -84.0% -87.4%
1.77 USD
Stock Price
0.22 USD
Fair Price

MRVI EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-04-21 155.68
2025-04-17 159.70
2025-04-16 155.24
2025-04-15 156.13
2025-04-14 159.70
2025-04-11 165.04
2025-04-10 160.59
2025-04-09 174.85
2025-04-08 169.50
2025-04-07 179.31
2025-04-04 174.85
2025-04-03 189.11
2025-04-02 198.92
2025-04-01 194.46
2025-03-31 198.92
2025-03-28 212.29
2025-03-27 211.40
2025-03-26 213.18
2025-03-25 206.94
2025-03-24 201.60
2025-03-21 203.82
2025-03-20 215.86
2025-03-19 218.53
2025-03-18 231.91
2025-03-17 237.26
2025-03-14 220.32
2025-03-13 217.64
2025-03-12 234.58
2025-03-11 237.26
2025-03-10 256.87
2025-03-07 265.78
2025-03-06 239.93
2025-03-05 252.41
2025-03-04 255.08
2025-03-03 271.13
2025-02-28 288.96
2025-02-27 273.81
2025-02-26 291.64
2025-02-25 281.83
2025-02-24 359.39
2025-02-21 368.30
2025-02-20 354.04
2025-02-19 365.63
2025-02-18 367.41
2025-02-14 376.33
2025-02-13 369.19
2025-02-12 381.68
2025-02-11 379.89
2025-02-10 385.24
2025-02-07 410.20